Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States
Addiction · 2026-09 · 121 (9) · 2450-2456
DOI: 10.1111/add.70410 ↗At a glance
Journal article in Addiction, published online on 2026-04-24. Written by Vijay M Tiyyala and 6 co-authors. Institution: Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA. Major MEDLINE topics: Drug and Narcotic Control, Public Opinion, Cannabis. 25 references. The full text is freely available in PubMed Central. Funded by: National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA), NCATS NIH HHS, NIDA NIH HHS.
Abstract (original language)
Aims
The United States Drug Enforcement Administration's (DEA) proposed rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act marks a significant shift in federal policy. Understanding public sentiment toward this policy is critical for guiding the current cannabis rescheduling effort as well as future reforms. The objective of this study is to characterize public comments submitted to Regulations.gov regarding the DEA's cannabis rescheduling proposal and identify underlying justifications for support or opposition.
Design
A mixed‐methods analysis was conducted.
Setting
Online public comments submitted to Regulations.gov regarding the DEA's cannabis rescheduling proposal.
Participants
42 913 public comments submitted between 21 May and 22 July 2024.
Measurements
Comments were analyzed for sentiment towards the proposed rescheduling (support, oppose or insufficient rescheduling) and thematic justifications using manual and automated natural language processing techniques. A two‐stage annotation approach was employed: manual coding of 200 randomly sampled comments by multiple independent evaluators, followed by automated classification of all 42 913 comments using open source Large Language Model (LLM) validated against the manual annotations.
Findings
Using LLM‐based classification validated against human annotations [88% agreement, F1 (harmonic mean of precision and recall) = 0.86], we found that among 42 913 comments, 28.85% [95% confidence interval (CI) = 28.44%–29.24%] supported rescheduling, 6.74% (95% CI = 6.50%–6.99%) opposed and 63.50% (95% CI = 63.06%–63.99%) deemed the proposal insufficient, favoring further rescheduling or complete de‐scheduling of cannabis. Among the 200 manually annotated comments, therapeutic benefits (56.7%, 95% CI = 46.7%–66.7%) and economic impacts (27.8%, 95% CI = 18.9%–37.8%) were the most common justifications among supporters. Public health risks (100.0%, 95% CI = 100.0%–100.0%), addictiveness concerns (71.4%, 95% CI = 42.9%–100.0%) and concerns about underage use (57.1%, 95% CI = 14.3%–85.7%) were predominant in opposing comments. Insufficient rescheduling comments cited therapeutic benefits (37.8%, 95% CI = 28.5%–48.0%), economic impacts (28.6%, 95% CI = 19.4%–37.8%) and criminal justice reform (26.5%, 95% CI = 18.4%–35.7%) as primary justifications.
Conclusions
Public sentiment on Regulations.gov supports the United States Drug Enforcement Administration's proposal for cannabis rescheduling, though the majority views the proposed Schedule III classification as inadequate and supports further rescheduling or complete de‐scheduling of cannabis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA.
- Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
- Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
- Centre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.
- Altman Clinical Translational Research Institute, University of California San Diego, La Jolla, CA, USA.
ORCID profiles: Cerina Dubois, Ryan Vandrey, Johannes Thrul, Mark Dredze, John W Ayers
Funding
- National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA)
- NCATS NIH HHS
- NIDA NIH HHS
- Burroughs Wellcome Fund for Innovations in Regulatory Science
Cite
APA
Tiyyala, V. M., Dubois, C., Madar, C., Vandrey, R., Thrul, J., Dredze, M., & Ayers, J. W. (2026). Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States. Addiction, 121(9), 2450-2456. https://doi.org/10.1111/add.70410
Vancouver
Tiyyala VM, Dubois C, Madar C, Vandrey R, Thrul J, Dredze M, et al. Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States. Addiction. 2026;121(9):2450-2456. doi:10.1111/add.70410
BibTeX
@article{Tiyyala2026,
author = {Tiyyala, Vijay M and Dubois, Cerina and Madar, Clarissa and Vandrey, Ryan and Thrul, Johannes and Dredze, Mark and Ayers, John W},
title = {Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States},
journal = {Addiction},
year = {2026},
volume = {121},
number = {9},
pages = {2450--2456},
doi = {10.1111/add.70410}
}
EUVIMED